Pharmaceutical Technology
August 02, 2010
Online Exclusives
34
8
The updated edition of William Whyte's book provides information for novices and seasoned professionals alike.
August 02, 2010
Online Exclusives
34
8
The author reviews test methods for microbiological cleaning processes and suggests ways to improve microbial bioburden method suitability studies.
August 02, 2010
Online Exclusives
34
8
Serialized product codes serve as the foundation of ePedigree records and product traceability.
August 02, 2010
Washington Report
34
8
Fallout escalates from McNeil recall and Genzyme shortages as regulators review oversight.
August 02, 2010
From The Editor
34
8
Industry's focus on cost cutting has led to a dangerous gap in training and knowledge.
August 02, 2010
Peer-Reviewed
34
8
The authors discuss the statistical tools used in experimental planning and stategy and how to evaluate the resulting design space and its graphical representation.
August 02, 2010
Agent-in Place
34
8
Cases of overlooking proper packaging, reconstitution, directions, and dissolution.
August 02, 2010
Special Report
34
8
FDA chemistry reviewers in the Office of Generic Drugs provide an overview of common deficiences cited throughout the Chemistry, Manufacturing, and Controls section of ANDAs.
August 02, 2010
News
34
8
Manufacturers and regulators on both sides of the ocean move to ensure the safety of heparin and other globally distributed drug products.
August 02, 2010
Industry Leaders
34
8
The president of Jost Chemical talks about client demands, supplier audits, and more.
August 02, 2010
Viewpoint
34
8
Industry can meet its responsibility to society by considering innovative pricing and partnerships.
August 02, 2010
Special Report
34
8
Pharmaceutical Technology's annual analysis of the pharmaceutical majors' activities shows a shrinking global manufacturing network amidst company restructuring, product intensification in biologics, and a strategic focus and push to emerging markets.
August 02, 2010
Peer-Reviewed
34
8
The authors used common solvents to develop an initial solvent-screening method for laboratory-scale research to determine the solubility, polymorphism, and crystal properties of various active ingredients.
August 02, 2010
Outsourcing Outlook
34
8
Relationship management is a limiting factor to growth in biomanufacturing outsourcing.
August 02, 2010
In the Spotlight
34
8
Editors' picks of pharmaceutical science and technology innovations.
August 02, 2010
Special Report
34
8
Pharmaceutical Technology talked to experts in siRNA-drug development to gain insight into the characteristics, processes, and challenges of this class of therapeutics.
August 02, 2010
Ingredients Insider
34
8
Chemocatalytic and biocatalytic approaches in asymmetric synthesis help provide a pathway for producing single-enantiomer drugs.
August 02, 2010
Ingredients Insider
34
8
Green chemistry in pharmaceutical development often centers around approaches in the synthesis of the active ingredient, but green-chemistry techniques also can be applied to drug-product manufacturing, formulation development, and drug delivery.
August 02, 2010
PharmTech Talk
34
8
Three therapies under review could help Americans attain a healthy weight.
August 02, 2010
Insider Solutions
34
8
Before embarking on an outsourcing relationship, it's important to be aware of FDA's expectations.
August 01, 2010
Issue PDF
34
8
Big Pharma?s Manufacturing Strategy: What is the Next Move?